Mursla Limited
Company Bio
EvoLiver™ is a blood-based test for the early detection of liver cancer. The current standard of care has low early-stage sensitivity (~40%) and poor patient adherence, creating a clear need for a highly accurate, accessible, patient-friendly test.
EvoLiver™ addresses this need by combining AI and extracellular vesicle analysis from a simple blood draw enabling earlier, more reliable detection of HCC with high accuracy.
